Fondation André-Delambre - ALS
Home The Foundation Events Symposium Research Supporters Media Collaborators Contact  

"A spark that lights the way toward a solution"

-André Delambre
Symposium- Archives
Symposium - 2010

6th Symposium of the Fondation André-Delambre on Amyotrophic Lateral Sclerosis

Sponsored by the Fondation André-Delambre and now in its sixth year, the Symposium on amyotrophic lateral sclerosis is rapidly becoming one of the top tickets in ALS research. The meeting, held September 24-25 at Université Laval in Québec City, Canada, attracted 80 scientists who discussed cutting-edge data on the mechanisms of the disease and progress on treatments and in the stem cell field. “Speakers presented an avalanche of results that we have to think about,” said Jean-Pierre Julien of Université Laval in a closing statement. Julien co-organized the meeting with Jasna Kriz, also at Laval.

En Lire Plus

Symposium - 2009

5th Symposium of the Fondation André-Delambre on Amyotrophic Lateral Sclerosis

“Researchers need to meet each year to advance the cause of research into ALS.” This was the message of Monica Lalancette, neurologist and researcher at CHU Université Laval, and of Jean-Pierre Julien, a professor at Université Laval. The gathering of experts from around the world became a reality at the 5th Symposium on Amyotrophic Lateral Sclerosis. Some 100 invited guests attended a series of talks on the clinical promise of stem cells, organogenesis and genetics. “The symposium also included students,” Nicolas Dupré, neurologist at Hôpital de l’Enfant-Jésus and associate professor at Université Laval, points out. “It’s a way of encouraging them to consider a career in ALS research, rather than in another field.

En Lire Plus

Symposium - 2008 Montreal, 25-26 September 2008 - Some 150 researchers attended the fourth ALS Symposium of the Fondation André-Delambre at the Montreal Neurological Institute

The fourth Symposium on ALS funded by the Fondation André-Delambre was a success, thanks not only to the number of participants but mostly to the high scientific level of discussions, the participants’ enthusiasm and the quantity of groundbreaking results presented by the speakers. We had two days of intense debates on cutting-edge ALS research. What distinguished this annual symposium from other gatherings was the friendly atmosphere that encouraged exchanges between participants. One of the major outcomes of the symposium was the establishment of new collaborations between participating researchers. We hope that these collaborations will help speed up progress in research and move us closer to the goal of finding a therapeutic cure to stop this terrible disease.

En Lire Plus
Symposium - 2007

Approximately 100 research scientists at the Montreal Neurological Institute for the third Symposium on ALS presented by the Fondation André-Delambre (October 4–5, 2007)

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease or Charcot’s disease, is a devastating, incurable disease characterized by a progressive loss of motor neurons, which gradually leads to paralysis and, in most cases, death from respiratory failure within a few years of diagnosis. On October 4 and 5, 2007, the Montreal Neurological Institute hosted the Fondation André-Delambre’s third annual Symposium on ALS.

En Lire Plus

Symposium - 2006 Québec, September 8-9, 2006 – The Fondation André-Delambre’s 2nd Symposium was a success, not only because of the number of participants but especially because of the high scientific level of the discussions, the enthusiasm of the participants and the quantity of previously unpublished results presented by the speakers. What makes this annual Symposium stand out is the friendly atmosphere, which is conducive to dialogue among participants. Moreover, an important positive effect of the Symposium was the establishment of several new cooperative ventures among participating researchers. We hope that these cooperative projects will allow research to move forward more quickly and get closer to the objective of finding a therapeutic approach that can stop this terrible illness.

Read More
Symposium - 2005 Montreal, August 31, 2005 – The disease has all the makings of an international assassin; it is known by many names, it strikes when you least expect it, and most of the people it touches die. There is no cure for amyotrophic lateral sclerosis (ALS), known in different countries as Lou Gehrig’s, Sue Rodriguez’s or Charcot’s disease; sadly, it kills two to five Canadians a day. The Fondation André Delambre (FAD) wants this killer stopped and is turning to medical researchers for help.  FAD will sponsor its first international ALS Symposium September 9 to 10, 2005 at the Montreal Neurological Institute and Hospital. Scientists from three continents will convene to discuss causes of the disease and novel approaches to its treatment including, stem cell and gene therapy.

Read More
Fondation André-Delambre

2540, Daniel-Johnson, #755
Laval (Québec) H7T 2S3

Tel: (450) 978-3555
Fax: (450) 978-1055

La Fondation André-Delambre All rights reserved ©2012
Site hosted by
web design: Saffronweb